Last reviewed · How we verify
US sourced Humira®
US sourced Humira® is a Biologic drug developed by Samsung Bioepis Co., Ltd.. It is currently in Phase 1 development.
At a glance
| Generic name | US sourced Humira® |
|---|---|
| Sponsor | Samsung Bioepis Co., Ltd. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- US sourced Humira® CI brief — competitive landscape report
- US sourced Humira® updates RSS · CI watch RSS
- Samsung Bioepis Co., Ltd. portfolio CI
Frequently asked questions about US sourced Humira®
What is US sourced Humira®?
US sourced Humira® is a Biologic drug developed by Samsung Bioepis Co., Ltd..
Who makes US sourced Humira®?
US sourced Humira® is developed by Samsung Bioepis Co., Ltd. (see full Samsung Bioepis Co., Ltd. pipeline at /company/samsung-bioepis-co-ltd).
What development phase is US sourced Humira® in?
US sourced Humira® is in Phase 1.
Related
- Manufacturer: Samsung Bioepis Co., Ltd. — full pipeline
- Compare: US sourced Humira® vs similar drugs
- Pricing: US sourced Humira® cost, discount & access